CASC3 and Miyoshi myopathy: Liu et al. (2020) showed that circITCH, downregulated in MM, restores bortezomib (BTZ) sensitivity via the miR-615-3p/PRKCD axis, with circITCH overexpression enhancing BTZ response [49].